Geng Dongxue, Lv Nan, Miao Yi
Department of Pancreas Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210009, China.
Department of Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, 210029, China.
BMC Cancer. 2025 May 29;25(1):965. doi: 10.1186/s12885-025-14377-5.
Biliary stent placement is widely used in clinical, especially in patients with pancreatic cancer complicated with obstructive jaundice. Pyogenic liver abscess (PLA) is a severe complication following biliary stent placement which predominantly occurs in the right lobe of the liver, with an incidence rate ranging from 4.3% to 13.5% and a mortality rate up to 30%. It is related to the following mechanisms: retrograde bacterial infection; bile stasis and increased bile duct pH; stent-related bile duct injury; biofilm formation; immune system suppression. The main causative pathogens are gram-negative bacilli, particularly Escherichia coli and Klebsiella pneumoniae. The combination of antibiotic therapy and percutaneous transhepatic abscess drainage is the main treatment option.
胆道支架置入术在临床上广泛应用,尤其是在合并梗阻性黄疸的胰腺癌患者中。化脓性肝脓肿(PLA)是胆道支架置入术后的一种严重并发症,主要发生在肝右叶,发病率为4.3%至13.5%,死亡率高达30%。其与以下机制有关:逆行细菌感染;胆汁淤积和胆管pH值升高;支架相关胆管损伤;生物膜形成;免疫系统抑制。主要致病菌为革兰氏阴性杆菌,尤其是大肠杆菌和肺炎克雷伯菌。抗生素治疗联合经皮肝穿刺脓肿引流是主要的治疗选择。